Role of T Cell Mediated Immunity In Emotion And Stress Responsiveness

T 细胞介导的免疫在情绪和压力反应中的作用

基本信息

  • 批准号:
    8265622
  • 负责人:
  • 金额:
    $ 18.75万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2011
  • 资助国家:
    美国
  • 起止时间:
    2011-06-01 至 2014-05-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): A significant number of studies report that individuals suffering from chronic inflammatory diseases including allergic and autoimmune diseases have a higher incidence of psychiatric complications related to increased emotional reactivity and poor coping responses to stress. Such mental complications including depression and anxiety disorders impose a great burden to these patients which has been also related to the poor prognosis of the inflammatory condition. The reasons for this association are poorly understood and research on potential mechanisms is lacking. Results from our studies and those of our collaborator show that in experimentally controlled conditions, behavioral alterations indicative of increased emotional reactivity develop as a result of the activity of peripheral lymphocytes which are responsible for the initiation and maintenance of inflammatory diseases. There is however significant controversy if the activity of these immune cells is directly related with neurobehavioral mechanisms or if it is a phenomenon that develops in parallel with other neuroimmunological processes responsible for the manifestation of behavioral pathology. The present application will evaluate if activated T lymphocytes in the periphery are necessary and sufficient to induce emotional behavioral changes. Using state of the art methods in immunology by employing the RAG2-/- deficient mice which lacks mature T lymphocytes, we plan to assess if reconstitution by adoptive transfer of in vitro differentiated T cells is a condition capable of inducing altered emotional behavior and deficient responses to psychogenic stressors. RAG2-/- mice will be reconstituted with either in vitro differentiated TH1 or TH2 cells obtained from RAG2 D011.10 transgenic mice. These mice express the transgene for the T-cell antigen receptor that is specific for ovalbumin and therefore these animals do contain OVA specific T-cells. Groups of reconstituted mice will be then challenged with OVA antigen and evaluated in the open field, elevated plus maze, social interaction and sucrose preference tests. Control groups will consist of naive RAG2-/- mice under different immunization protocols and reconstituted RAG2-/- mice not immunized (not activated). Based on our recent studies about trafficking of activated T cells into the brain and their effects on cytokine expression, their presence in the brain will be studied by immunohistochemistry and cytokine mRNA expression by real-time RT-PCR. These experiments are proposed within the framework of an R21 application to test if differences on behavior under the different reconstitution strategies are quantifiable. These studies may provide a working model to further study the mechanisms by which lymphocytes exert specific effects on brain function and behavior and yield valuable information on neuroimmune mechanisms involving the adaptive arm of the immune response. This may advance the understanding of mind-body interaction and lead to the development of new strategies of interventions to improve the treatment of mental disorders in chronically ill patients.
描述(由申请人提供):大量研究报告称,患有慢性炎症性疾病(包括过敏性和自身免疫性疾病)的个体具有较高的精神并发症发生率,这些并发症与情绪反应性增加和对压力的应对反应较差有关。包括抑郁症和焦虑症在内的精神并发症给这些患者带来了巨大的负担,这也与炎症性疾病的不良预后有关。人们对这种关联的原因知之甚少,也缺乏对潜在机制的研究。我们和我们合作者的研究结果表明,在实验控制的条件下,由于外周淋巴细胞的活动而导致情绪反应性增加的行为改变,而外周淋巴细胞负责炎症疾病的引发和维持。然而,如果这些免疫细胞的活性与神经行为机制直接相关,或者它是否是与导致行为病理学表现的其他神经免疫过程并行发展的现象,则存在重大争议。本申请将评估外周激活的T淋巴细胞是否必要且足以诱导情绪行为变化。通过使用缺乏成熟T淋巴细胞的RAG2-/-缺陷小鼠,我们计划利用免疫学中最先进的方法来评估通过体外分化T细胞的过继转移进行重建是否是一种能够诱导情绪行为改变和对心因性应激源反应不足的条件。 RAG2-/-小鼠将用从RAG2 D011.10转基因小鼠获得的体外分化的TH1或TH2细胞进行重建。这些小鼠表达卵清蛋白特异性 T 细胞抗原受体转基因,因此这些动物确实含有 OVA 特异性 T 细胞。然后用OVA抗原攻击重组小鼠组,并在旷场、高架十字迷宫、社交互动和蔗糖偏好测试中进行评估。对照组将由不同免疫方案下的初始RAG2-/-小鼠和未免疫(未激活)的重组RAG2-/-小鼠组成。根据我们最近关于活化 T 细胞进入大脑及其对细胞因子表达的影响的研究,将通过免疫组织化学和实时 RT-PCR 的细胞因子 mRNA 表达来研究它们在大脑中的存在。这些实验是在 R21 应用程序的框架内提出的,旨在测试不同重构策略下的行为差异是否可以量化。这些研究可能提供一个工作模型来进一步研究淋巴细胞对大脑功能和行为产生特定影响的机制,并产生涉及免疫反应适应性臂的神经免疫机制的有价值的信息。这可能会增进对身心相互作用的理解,并导致开发新的干预策略,以改善慢性病患者精神障碍的治疗。

项目成果

期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Dissociation between sickness behavior and emotionality during lipopolysaccharide challenge in lymphocyte deficient Rag2(-/-) mice.
  • DOI:
    10.1016/j.bbr.2014.09.030
  • 发表时间:
    2015-02-01
  • 期刊:
  • 影响因子:
    2.7
  • 作者:
    Clark, Sarah M.;Michael, Kerry C.;Klaus, Joseph;Mert, Abdullah;Romano-Verthelyi, Ari;Sand, Joseph;Tonelli, Leonardo H.
  • 通讯作者:
    Tonelli, Leonardo H.
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Leonardo H Tonelli其他文献

Leonardo H Tonelli的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Leonardo H Tonelli', 18)}}的其他基金

A translational model of neuro-immune therapy for PTSD in veterans of the OEF/OIF
OEF/OIF 退伍军人 PTSD 神经免疫治疗的转化模型
  • 批准号:
    8143156
  • 财政年份:
    2011
  • 资助金额:
    $ 18.75万
  • 项目类别:
Role of T Cell Mediated Immunity In Emotion And Stress Responsiveness
T 细胞介导的免疫在情绪和压力反应中的作用
  • 批准号:
    8113052
  • 财政年份:
    2011
  • 资助金额:
    $ 18.75万
  • 项目类别:
Neuroimmune Mechanisms of Risk and Resilience to Maladaptive Responses to Stress
压力适应不良反应的风险和复原力的神经免疫机制
  • 批准号:
    8546252
  • 财政年份:
    2011
  • 资助金额:
    $ 18.75万
  • 项目类别:
A translational model of neuro-immune therapy for PTSD in veterans of the OEF/OIF
OEF/OIF 退伍军人 PTSD 神经免疫治疗的转化模型
  • 批准号:
    8398929
  • 财政年份:
    2011
  • 资助金额:
    $ 18.75万
  • 项目类别:
Neuroimmune Mechanisms of Risk and Resilience to Maladaptive Responses to Stress
压力适应不良反应的风险和复原力的神经免疫机制
  • 批准号:
    8174102
  • 财政年份:
    2011
  • 资助金额:
    $ 18.75万
  • 项目类别:
Neuroimmune Mechanisms of Risk and Resilience to Maladaptive Responses to Stress
压力适应不良反应的风险和复原力的神经免疫机制
  • 批准号:
    8338854
  • 财政年份:
    2011
  • 资助金额:
    $ 18.75万
  • 项目类别:
A translational model of neuro-immune therapy for PTSD in veterans of the OEF/OIF
OEF/OIF 退伍军人 PTSD 神经免疫治疗的转化模型
  • 批准号:
    8310756
  • 财政年份:
    2011
  • 资助金额:
    $ 18.75万
  • 项目类别:
Intranasal immune challenge, brain cytokines and gender differences in depression
鼻内免疫挑战、脑细胞因子和抑郁症的性别差异
  • 批准号:
    7142457
  • 财政年份:
    2006
  • 资助金额:
    $ 18.75万
  • 项目类别:
Intranasal immune challenge, brain cytokines and gender differences in depression
鼻内免疫挑战、脑细胞因子和抑郁症的性别差异
  • 批准号:
    7267958
  • 财政年份:
    2006
  • 资助金额:
    $ 18.75万
  • 项目类别:
Role of Kynurenine System on Brain Inflammatory Responses in the Offspring of Immune Challenged Rats
犬尿氨酸系统对免疫缺陷大鼠后代脑炎症反应的作用
  • 批准号:
    8847403
  • 财政年份:
  • 资助金额:
    $ 18.75万
  • 项目类别:

相似海外基金

Time to ATTAC: Adoptive Transfer of T cells Against gp100+ Cells to treat LAM
ATTAC 时间:针对 gp100 细胞的 T 细胞过继转移来治疗 LAM
  • 批准号:
    10682121
  • 财政年份:
    2023
  • 资助金额:
    $ 18.75万
  • 项目类别:
Phase I clinical trial of adoptive transfer of autologous folate receptor-alpha redirected CAR T cells for ovarian cancer
自体叶酸受体-α重定向CAR T细胞过继转移治疗卵巢癌的I期临床试验
  • 批准号:
    10576370
  • 财政年份:
    2022
  • 资助金额:
    $ 18.75万
  • 项目类别:
Phase I clinical trial of adoptive transfer of autologous folate receptor-alpha redirected CAR T cells for ovarian cancer
自体叶酸受体-α重定向CAR T细胞过继转移治疗卵巢癌的I期临床试验
  • 批准号:
    10387023
  • 财政年份:
    2022
  • 资助金额:
    $ 18.75万
  • 项目类别:
Determining mechanisms of enhanced antitumor efficacy of four-day expanded Th17 cells for adoptive transfer
确定用于过继转移的四天扩增 Th17 细胞增强抗肿瘤功效的机制
  • 批准号:
    10248409
  • 财政年份:
    2019
  • 资助金额:
    $ 18.75万
  • 项目类别:
A phase I clinical study of adoptive transfer of regulatory T cells (Tregs) and low-dose interleukin-2 (IL-2) for the treatment of chronic graft-versus-host disease (GVHD): gene-marking to inform rational combination therapy
调节性 T 细胞 (Treg) 和低剂量白细胞介素 2 (IL-2) 过继转移治疗慢性移植物抗宿主病 (GVHD) 的 I 期临床研究:基因标记为合理的联合治疗提供信息
  • 批准号:
    nhmrc : GNT1163111
  • 财政年份:
    2019
  • 资助金额:
    $ 18.75万
  • 项目类别:
    Project Grants
Determining mechanisms of enhanced antitumor efficacy of four-day expanded Th17 cells for adoptive transfer
确定用于过继转移的四天扩增 Th17 细胞增强抗肿瘤功效的机制
  • 批准号:
    10462684
  • 财政年份:
    2019
  • 资助金额:
    $ 18.75万
  • 项目类别:
Gene edited lymphoid progenitors for adoptive transfer as a treatment of primary immunodeficiency
基因编辑的淋巴祖细胞用于过继转移作为原发性免疫缺陷的治疗
  • 批准号:
    398018062
  • 财政年份:
    2018
  • 资助金额:
    $ 18.75万
  • 项目类别:
    Research Grants
Overcoming immune suppression in cancer by targeting PSGL-1 in T cells used for adoptive transfer
通过靶向用于过继转移的 T 细胞中的 PSGL-1 克服癌症中的免疫抑制
  • 批准号:
    9308643
  • 财政年份:
    2017
  • 资助金额:
    $ 18.75万
  • 项目类别:
Overcoming immune suppression in cancer by targeting PSGL-1 in T cells used for adoptive transfer
通过靶向用于过继转移的 T 细胞中的 PSGL-1 克服癌症中的免疫抑制
  • 批准号:
    9447149
  • 财政年份:
    2017
  • 资助金额:
    $ 18.75万
  • 项目类别:
Targeting Cancer miRNAs by Adoptive Transfer of Programmed B Lymphocytes
通过程序化 B 淋巴细胞的过继转移靶向癌症 miRNA
  • 批准号:
    8893915
  • 财政年份:
    2014
  • 资助金额:
    $ 18.75万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了